Acta Med. 2001, 44: 7-13

https://doi.org/10.14712/18059694.2019.80

Light-Induced Photoactivation of Hypericin Inhibits Cellular Growth in Pituitary Adenoma Cell Line AtT20/D16v-F2 (Hypericin Inhibits Cellular Growth of AtT20/D16v-F2)

Martina Marekováa, Jiřina Vávrováb, Doris Vokurkovác, Jaroslav Cermana

aCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Medical Biochemistry, Hradec Králové, Czech Republic
bPurkyně Military Medical Academy in Hradec Králové, Department of Radiobiology and Immunology, Hradec Králové, Czech Republic
cUniversity Teaching Hospital, Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic

Received September 1, 2000
Accepted January 1, 2001

References

1. Carpenter S and Kraus GA. Photosensitization is required for inactivation of equine infectious anemia virus by hypericin. Photochem Photobiol 1991; 53(2): 169-74. <https://doi.org/10.1111/j.1751-1097.1991.tb03919.x>
2. Couldwell WT, Gopalakrishna R, Hinton DR et al. Hypericin: a potential antiglioma therapy (published erratum appears in Neurosurgery 1994 Nov;35(5):993). Neurosurgery 1994; 35(4):705-10. <https://doi.org/10.1227/00006123-199410000-00017>
3. De Witte P, Agostinis P, Van Lint J et al. Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin. Biochem Pharmacol 1993; 46(11):1929-36. <https://doi.org/10.1016/0006-2952(93)90633-8>
4. Durán N and Song PS. Hypericin and its photodynamic action. Photochem Photobiol 1986; 43(6):677-80. <https://doi.org/10.1111/j.1751-1097.1986.tb05646.x>
5. Fox FE, Niu Z, Tobia A et al. Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J Invest Dermatol 1998; 111(2):327-32. <https://doi.org/10.1046/j.1523-1747.1998.00278.x>
6. Hamilton HB, Hinton DR, Law RE et al. Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application. J Neurosurg 1996; 85(2): 329-34. <https://doi.org/10.3171/jns.1996.85.2.0329>
7. Harris MS, Sakamoto T, Kimura H et al. Hypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of protein kinase C. Curr Eye Res 1996; 15(3):255-62. <https://doi.org/10.3109/02713689609007619>
8. Hudson JB, Graham EA and Towers GH. Antiviral assays on phytochemicals: the influence of reaction parameters. Planta Med 1994; 60(4):329-32. <https://doi.org/10.1055/s-2006-959494>
9. Hudson JB, Lopez-Bazzocchi I and Towers GH. Antiviral activities of hypericin. Antiviral Res 1991; 15(2):101-12. <https://doi.org/10.1016/0166-3542(91)90028-P>
10. Lavie G, Valentine F, Levin B et al. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Acad Sci USA 1989; 86(15):5963-7. <https://doi.org/10.1073/pnas.86.15.5963> <PubMed>
11. Mareková M, Vávrová J, Vokurková D. Dose Dependent Biological Effects of Idarubicin in HL-60 Cells: Alterations of the Cell-cycle and Apoptosis. Acta Medica 2000; 43(2):69-73.
12. Mareková M, Vávrová J, Vokurková D. Ethanol Induced Apoptosis in Human Hl- 60 Cells. Gen Physiol Biophys 2000; in press.
13. Meruelo D, Lavie G and Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci U S A 1988; 85(14):5230-4. <https://doi.org/10.1073/pnas.85.14.5230> <PubMed>
14. Miccoli L, Beurdeley-Thomas A, De Pinieux G et al. Light-induced photoactivatiopn of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res 1998; 58:5777-86.
15. Takahashi I, Nakanishi S, Kobayashi E et al. Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem Biophys Res Commun 1989; 165(3):1207-12. <https://doi.org/10.1016/0006-291X(89)92730-7>
16. Tang J, Colacino JM, Larsen SH et al. Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antiviral Res 1990; 13(6):313-25. <https://doi.org/10.1016/0166-3542(90)90015-Y>
17. Utsumi T, Okuma M, Utsumi T et al. Light-Dependent Inhibition of Protein Kinase C and superoxide Generation of Neutrophils by Hypericin, an Antiretroviral Agent. Arch Biochem Biophys 1995; 316(1):493-7. <https://doi.org/10.1006/abbi.1995.1065>
18. Vantieghem A, Assefa Z, Vandenabeele P et al. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. FEBS Lett 1998; 440:19-24. <https://doi.org/10.1016/S0014-5793(98)01416-1>
19. Vávrová J, Mareková M, Vokurková D. Lidské hematologické nádorové linie a jejich citlivost k účinkům ionizujícího záření. Voj Zdrav Listy 2000; in press.
20. Yang X, Goncalves J and Gabuzda D. Phosphorylation of Vif and its role in HIV- 1 replication. J Biol Chem 1996; 271(17):10121-9. <https://doi.org/10.1074/jbc.271.17.10121>
21. Zhang W, Hinton DR, Surnock AA et al. Malignant glioma sensitivity to radiotherapy, high-dose tamoxifen, and hypericin: corroborating clinical response in vitro: case report. Neurosurgery 1996; 38(3):587-1.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive